PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation 2011/55/EU ,
Reg. (EU) No 2018/1266 ,
Reg. (EU) No 540/2011
   
Date of approval 01/06/2011 Expiration of approval 31/05/2023
RMS

Co-RMS
AT

RO
Risk Assessment EFSA
Category PG Review Report   Confirmatory data 2014
  Inclusion 2011
Remarks Initially non included by Decision 2008/934. Included as from 1 June 2011 following re-submission for inclusion according to Reg. 33/2008.

The original RMS was UK.
Type Candidate for Substitution (CfS) CfS - criteria two PBT criteria
Authorisation at national level
Authorised in In progress for
AT, BE, BG, CZ, DE, DK, EE, ES, FI, FR, HU, IE, IT, LT, LV, NL, RO, SE, SK, UK EL
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Paclobutrazol
    MRLs Annex II
Classification Reg. 1272/2008
No classification
Toxicological information
Reference values Source Remark
ADI 0.022 11/55/EU  
ARfD 0,1 11/55/EU  
AOEL 0,1 11/55/EU  
Other
 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level